In this study, which was performed on 279 ovarian tumors, the expression of HNF1β, Napsin A, and AMACR markers in 65 cases of CCC was obtained at 92%, 82%, and 63%, respectively. This evidence concerns the gene HNF1B and ovarian neoplasm.